The metagenomics market size is calculated at USD 2.68 billion in 2025 and is expected to reach around USD 8.39 billion by ...

Promoting interdisciplinary collaboration via molecular tumor boards and shared decision-making frameworks might improve the ...

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies ...

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.

Belantamab mafodotin (Blenrep), pomalidomide (Pomalyst), and dexamethasone (BPd) was well tolerated and led to deep responses in patients with high-risk multiple myeloma.

Early testing supports timely antivirals, curbs inappropriate antibiotic use, and helps health systems allocate resources ...

The oncology-based molecular diagnostics market is being propelled by the increasing prevalence of cancer worldwide and the ...

Alida Biosciences’ EpiPlex platform uses robust assay controls and specialized bioinformatics to detect RNA modification, genomic coordinates, and relative quantity.